CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative: CSF3R mutations can be detected in approximately 80% of patients with chronic neutrophilic leukemia (CNL), and CSF3R mutations are now used as specific diagnostic molecular markers for CNL and atypical chronic myeloid leukemia (aCML) (22).